Liver cirrhosis in cystic fibrosis--therapeutic implications and long term follow up. 1993

J Feigelson, and C Anagnostopoulos, and M Poquet, and Y Pecau, and A Munck, and J Navarro
Hopital Robert Debré, Paris.

Experience gained from liver studies in 450 patients with cystic fibrosis, seen in a 38 year period from 1964 to 1992, is surveyed. Of these, 31 (7%) showed findings that indicated multilobular cirrhosis. There was a slight but not significant male predominance: 19 males against 12 females. Liver disease had its onset during childhood in most cases. The natural course of liver disease and of cirrhosis is protracted. All patients were routinely evaluated by way of: (i) clinical examination, (ii) biochemical studies and specifically estimation of transaminases and gamma glutamyltransferase, and (iii) liver imaging, ultrasonography, and computed tomography. The study aimed to detect early liver disease, that is multilobular cirrhosis and its complications, with a view to optimal introduction of treatment with ursodeoxycholic acid as this drug shows promise for preventing or stabilising the cirrhotic process. Effects of surgical treatment on portal hypertension are surveyed. These include portacaval shunting, partial splenectomy (considered the procedure of choice), liver transplant in the event of liver failure, or a triple transplant (liver, lungs, and heart) if necessary. One triple transplant was successfully performed in a boy of 10 years with a 2 year follow up.

UI MeSH Term Description Entries
D006975 Hypertension, Portal Abnormal increase of resistance to blood flow within the hepatic PORTAL SYSTEM, frequently seen in LIVER CIRRHOSIS and conditions with obstruction of the PORTAL VEIN. Cruveilhier-Baumgarten Disease,Cruveilhier-Baumgarten Syndrome,Cruveilhier Baumgarten Disease,Cruveilhier Baumgarten Syndrome,Disease, Cruveilhier-Baumgarten,Portal Hypertension,Portal Hypertensions,Syndrome, Cruveilhier-Baumgarten
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008297 Male Males
D011167 Portacaval Shunt, Surgical Surgical portasystemic shunt between the portal vein and inferior vena cava. Eck Fistula,Portacaval Anastomosis,Portacaval Shunt,Shunt, Surgical Portacaval,Surgical Portacaval Shunt,Anastomoses, Portacaval,Anastomosis, Portacaval,Fistula, Eck,Portacaval Anastomoses,Portacaval Shunts,Portacaval Shunts, Surgical,Shunt, Portacaval,Shunts, Portacaval,Shunts, Surgical Portacaval,Surgical Portacaval Shunts
D002423 Cause of Death Factors which produce cessation of all vital bodily functions. They can be analyzed from an epidemiologic viewpoint. Causes of Death,Death Cause,Death Causes
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003550 Cystic Fibrosis An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION. Mucoviscidosis,Cystic Fibrosis of Pancreas,Fibrocystic Disease of Pancreas,Pancreatic Cystic Fibrosis,Pulmonary Cystic Fibrosis,Cystic Fibrosis, Pancreatic,Cystic Fibrosis, Pulmonary,Fibrosis, Cystic,Pancreas Fibrocystic Disease,Pancreas Fibrocystic Diseases
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J Feigelson, and C Anagnostopoulos, and M Poquet, and Y Pecau, and A Munck, and J Navarro
August 1983, Klinicheskaia meditsina,
J Feigelson, and C Anagnostopoulos, and M Poquet, and Y Pecau, and A Munck, and J Navarro
May 1994, The Italian journal of gastroenterology,
J Feigelson, and C Anagnostopoulos, and M Poquet, and Y Pecau, and A Munck, and J Navarro
January 2011, Transplantation proceedings,
J Feigelson, and C Anagnostopoulos, and M Poquet, and Y Pecau, and A Munck, and J Navarro
June 2008, Pediatric pulmonology,
J Feigelson, and C Anagnostopoulos, and M Poquet, and Y Pecau, and A Munck, and J Navarro
January 2015, World journal of gastroenterology,
J Feigelson, and C Anagnostopoulos, and M Poquet, and Y Pecau, and A Munck, and J Navarro
May 1989, Archives des maladies du coeur et des vaisseaux,
J Feigelson, and C Anagnostopoulos, and M Poquet, and Y Pecau, and A Munck, and J Navarro
August 2012, Alimentary pharmacology & therapeutics,
J Feigelson, and C Anagnostopoulos, and M Poquet, and Y Pecau, and A Munck, and J Navarro
October 1978, Acta hepato-gastroenterologica,
J Feigelson, and C Anagnostopoulos, and M Poquet, and Y Pecau, and A Munck, and J Navarro
August 1997, Ear, nose, & throat journal,
J Feigelson, and C Anagnostopoulos, and M Poquet, and Y Pecau, and A Munck, and J Navarro
June 2022, Pediatric pulmonology,
Copied contents to your clipboard!